Archive

Filter

All three of our Special Situations Portfolio "cancer stocks" - companies that are on the cutting edge of developing revolutionary treatment for some of the worst forms of cancer, were in the news recently. And almost all of the news was good, with all three stocks moving up smartly as a result. Read More

As described in today’s issue of Smart Tech Investor, we are adding the three cancer-fighting companies described in our recent special report, “One Little Shot to Kill Cancer Dead“, to the new STI Special Situations Portfolio. Those stocks are Argos Therapeutics (ARGS), Juno Therapeutics (JUNO), and Ziopharm Oncology (ZIOP). Read More

As described in today’s issue of Smart Tech Investor, we are adding the three cancer-fighting companies described in our recent special report, “One Little Shot to Kill Cancer Dead“, to the new STI Special Situations Portfolio. Those stocks are Argos Therapeutics (ARGS), Juno Therapeutics (JUNO), and Ziopharm Oncology (ZIOP). Read More

Due to last Monday’s Presidents Day holiday the stock market was open for only four days last week instead of the usual five, but that’s all the time it needed to gain nearly 3% – one of its strongest showings in 2016. In fact, after hitting its closing low of… Read More

Securing data that doesn’t easily fit into a spreadsheet is becoming more critical. Since half of all data breaches these days involve some form of unstructured data (everything from text to video images), decision-makers higher up in organizations are now much more interested in learning how to best protect critical… Read More